Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Comments

Loading...

Merck Stock News

MKKGYOTCPK

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$28.02

0.140.50%

Last update: Dec 18, 11:20 AM

News

Short Interest Government Trades

Latest Merck Stock News | OTC:MKKGY | Benzinga

Get the latest news on Merck stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Merck performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, December 18, 2025

White House Readies Drug Price Deals With AbbVie, Novartis, Roche
Vandana Singh

Friday, October 17, 2025

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times
Vandana Singh
EMD Serono, CVS Health To Partner On TrumpRx Fertility Program Launching In 2026
Vandana Singh

Monday, August 11, 2025

Avantor Stock Jumps As Activist Investor Urges Sale, Board Shake-Up, And Cost Cuts
Vandana Singh

Monday, April 28, 2025

SpringWorks Therapeutics To Be Acquired by Me...
Benzinga Newsdesk

Sunday, February 16, 2025

WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
Lekha Gupta

Tuesday, February 11, 2025

Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics
Vandana Singh

Monday, January 13, 2025

GSK To Buy US-Based Stomach Cancer Drug Developer For Over $1 Billion
Vandana Singh

Monday, March 04, 2024

C4 Therapeutics Has Entered Into A License Ag...
Benzinga Newsdesk

Tuesday, December 12, 2023

Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition
Vandana Singh

Wednesday, December 06, 2023

Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
Vandana Singh

Tuesday, September 26, 2023

Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors
Vandana Singh

Wednesday, September 20, 2023

Exscientia And Merck Collaborate On AI-Driven...
Benzinga Newsdesk

Thursday, August 03, 2023

Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023
Vandana Singh

Wednesday, July 26, 2023

Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
Vandana Singh

Tuesday, June 20, 2023

Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
Vandana Singh

Tuesday, April 18, 2023

Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
Vandana Singh

Wednesday, April 12, 2023

FDA Issues Partial Clinical Hold On Merck Germany's Multiple Sclerosis Study
Vandana Singh

Monday, March 27, 2023

Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
Vandana Singh

Thursday, March 23, 2023

Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
Vandana Singh

Friday, January 20, 2023

With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics
Vandana Singh

Tuesday, January 03, 2023

PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment
Vandana Singh

Friday, December 23, 2022

Mersana Inks Cancer Therapy Development Deal With Merck Germany
Vandana Singh

Wednesday, October 19, 2022

SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19
Vandana Singh
Germany's Merck Slapped With Formal French Investigation Related To Its Thyroid Drug
Vandana Singh

Tuesday, October 11, 2022

PDS Biotech Highlights Expanded Data From PDS0101 Triple Combination Trial In HPV-Positive Cancers
Vandana Singh

Thursday, June 02, 2022

Oncolytics Reports Partnering With Biopharma Industry Leaders To Fast-Track Immunotherapy Treatment
Rachael Green - Sponsored

Tuesday, May 31, 2022

Germany's Merck To Launch Semiconductor Base In China
Anusuya Lahiri

Wednesday, February 16, 2022

Oncolytics Reports Foothold In Chinese Pharmaceutical Market With Latest Breast Cancer Clinical Trials
Rachael Green - Sponsored

Monday, January 24, 2022

TSMC Looks To Hire Over 8,000 People In 2022
Anusuya Lahiri

Thursday, January 13, 2022

This Biotech Is Working With Pfizer, Merck KGaA, Roche, and Other Leaders To Develop a Better Standard of Care for Breast Cancer
Rachael Green - Sponsored

Thursday, November 18, 2021

The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
Shanthi Rexaline

Thursday, September 30, 2021

GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact
Vandana Singh

Tuesday, September 21, 2021

Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
Vandana Singh

Tuesday, August 24, 2021

Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial
Vandana Singh

Tuesday, June 01, 2021

Sutro Biopharma Receives Undisclosed Milestone Payment Under Bispecific ADC Collaboration with Merck
Vandana Singh
Immutep, Merck Germany Team Up for Eftilagimod/Bintrafusp Combo Trial In Solid Tumors
Vandana Singh

Friday, May 14, 2021

Gene Therapy Player Vera Therapeutics Prices IPO Well Below Range At $11/Share
Vandana Singh

Monday, May 10, 2021

UK's NICE Provisionally Rejects Coverage Of Pfizer-Merck KGaA's Bavencio As First-Line Therapy For Bladder Cancer
Vandana Singh

Friday, April 09, 2021

The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
Shanthi Rexaline

Wednesday, April 07, 2021

Novartis Taps Artios In Discovery Pact To Enhance Radioligand Portfolio
Vandana Singh

Thursday, March 18, 2021

Exelixis' XL092 To Be Tested In Combination With Bavencio In Urothelial Carcinoma
Vandana Singh

Wednesday, March 17, 2021

Germany's Merck Invests In French Facility For Single Use Products
Vandana Singh

Tuesday, November 17, 2020

13 International Companies Giving Public Investor Presentations This Week
Spencer Israel

Wednesday, July 01, 2020

The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes
Shanthi Rexaline

Tuesday, March 24, 2020

Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights

Tuesday, March 17, 2020

10 International ADR Companies That Are Conducting Virtual Investor Presentations This Week
Spencer Israel

Wednesday, February 19, 2020

Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin

Friday, January 24, 2020

Stocks That Hit 52-Week Highs On Friday
Lisa Levin

Friday, January 10, 2020

Stocks That Hit 52-Week Highs On Friday
Lisa Levin

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved